Charu Sharma, H. Shah, N. Shenoy, D. Makhija, Mukta Waghmare
{"title":"1例女孩卵巢卵黄囊肿瘤病例报告","authors":"Charu Sharma, H. Shah, N. Shenoy, D. Makhija, Mukta Waghmare","doi":"10.34763/devperiodmed.20172102.101103","DOIUrl":null,"url":null,"abstract":"Abstract Yolk sac tumours are rare ovarian malignancies accounting for less than 1% of malignant ovarian germ cell tumours. They are mostly seen in adolescents and young women and are usually unilateral making fertility preservation imperative. Raised alpha-feto protein level is the hallmark of this tumour. We describe stage III yolk sac tumour in a girl child.","PeriodicalId":254970,"journal":{"name":"Developmental Period Medicine","volume":"13 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Ovarian Yolk Sac Tumour in a Girl − Case Report\",\"authors\":\"Charu Sharma, H. Shah, N. Shenoy, D. Makhija, Mukta Waghmare\",\"doi\":\"10.34763/devperiodmed.20172102.101103\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract Yolk sac tumours are rare ovarian malignancies accounting for less than 1% of malignant ovarian germ cell tumours. They are mostly seen in adolescents and young women and are usually unilateral making fertility preservation imperative. Raised alpha-feto protein level is the hallmark of this tumour. We describe stage III yolk sac tumour in a girl child.\",\"PeriodicalId\":254970,\"journal\":{\"name\":\"Developmental Period Medicine\",\"volume\":\"13 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Developmental Period Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34763/devperiodmed.20172102.101103\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Developmental Period Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34763/devperiodmed.20172102.101103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract Yolk sac tumours are rare ovarian malignancies accounting for less than 1% of malignant ovarian germ cell tumours. They are mostly seen in adolescents and young women and are usually unilateral making fertility preservation imperative. Raised alpha-feto protein level is the hallmark of this tumour. We describe stage III yolk sac tumour in a girl child.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
